Home > Financial Ratios > ONESOURCE SPECIALTY PHARMA

ONESOURCE SPECIALTY PHARMA
Core EBITDA Margin

    Back to All Ratios
ONESOURCE SPECIALTY PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ONESOURCE SPECIALTY PHARMA
Please provide your vote to see the results

ONESOURCE SPECIALTY PHARMA Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2025Mar2024Mar2023
   Core EBITDA Margin(%) 28.09-50.91-414.89

What is the latest Core EBITDA Margin ratio of ONESOURCE SPECIALTY PHARMA ?

The latest Core EBITDA Margin ratio of ONESOURCE SPECIALTY PHARMA is 28.09 based on Mar2025 Standalone results.
Year Core EBITDA Margin
Mar202528.09
Mar2024-50.91
Mar2023-414.89

How is Core EBITDA Margin of ONESOURCE SPECIALTY PHARMA Trending?

Years Core EBITDA Margin % Change
Mar2025 28.09
Positive
Mar2024 -50.91
Negative
Mar2023 -414.89 -

Other Financial Ratios of ONESOURCE SPECIALTY PHARMA


Compare Core EBITDA Margin ratio of peers of ONESOURCE SPECIALTY PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA ₹18,644.8 Cr 0.1% -12.4% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,412.0 Cr -0.4% 6.4% 4.2% Stock Analytics
DIVIS LABORATORIES ₹170,343.0 Cr -1.5% -4.9% 7.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,191.0 Cr -0.7% 4.8% 16.6% Stock Analytics
CIPLA ₹122,511.0 Cr -0.5% 1% 2.1% Stock Analytics
DR REDDYS LABORATORIES ₹106,523.0 Cr 2.2% 6.6% 5.7% Stock Analytics


ONESOURCE SPECIALTY PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA

0.1%

-12.4%

NA
SENSEX

0.7%

0.9%

6.1%


You may also like the below Video Courses